 |
|
|
| |
Lack of PK Interaction Between the Hepatitis C Virus Non-Structural Protein 5A Inhibitor MK-8742 and Methadone in Subjects on Stable Opiate Maintenance Therapy
|
| |
| |
Reported by Jules Levin
HEP DART 2013 December 8-12
Biennial Frontiers in Drug Development for Viral Hepatitis, The Big Island, Hawaii
AASLD: Merck at AASLD - (11/18/13)
William Marshall1, Patricia Jumes1, Wendy Yeh1, Rachel Liu1, Joanne Ma1, Eric Mangin1, Lynn R Webster2, Joan R Butterton1
1Merck Sharp & Dohme, Whitehouse Station, NJ, USA; 2Lifetree Clinical Research, Salt Lake City, UT, USA
|
| |
|
|
|
|
|
